TRHC Insider Trading Activity and SEC Form 4 Filings
TRHC insider trading summary
No open-market insider purchases or sales of Tabula Rasa HealthCare, Inc. (TRHC) have been reported on SEC Form 4 in the past 12 months.
Latest TRHC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2022 | Thomas Cancro | Chief Financial Officer | Buy | $50K (11,500 @ $4.34) |
| Dec 9, 2022 | Michael J. Purcell | Insider | Sell | $43K (10,000 @ $4.26) |
| Jul 25, 2022 | Ic Gp, LLC | 10% Owner | Buy | $254K (59,262 @ $4.28) |
| Jul 25, 2022 | Indaba Capital Management, L.P. | 10% Owner | Buy | $254K (59,262 @ $4.28) |
| Jul 25, 2022 | Derek C Schrier | 10% Owner | Buy | $254K (59,262 @ $4.28) |
| Jul 22, 2022 | Derek C Schrier | 10% Owner | Buy | $419K (103,292 @ $4.06) |
| Jul 22, 2022 | Ic Gp, LLC | 10% Owner | Buy | $399K (90,000 @ $4.43) |
| Jul 22, 2022 | Derek C Schrier | 10% Owner | Buy | $399K (90,000 @ $4.43) |
| Jul 22, 2022 | Indaba Capital Management, L.P. | 10% Owner | Buy | $419K (103,292 @ $4.06) |
| Jul 22, 2022 | Indaba Capital Management, L.P. | 10% Owner | Buy | $422K (100,000 @ $4.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.